CIPLA LTD vs PRAMODINI MEDICARE LTD
A side-by-side comparison of CIPLA LTD (CIPLA) and PRAMODINI MEDICARE LTD (PRAMODINI) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
CIPLA LTD vs PRAMODINI MEDICARE LTD are evenly matched on the numbers (6–6, 2 undecided). The breakdown below shows where each one wins.
- Valuation22
- Profitability04
- Growth· not comparable—
- Size & financial health40
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
PRAMODINI takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
CIPLA takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
- − ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.24%"]
- + ["Company has a good return on equity (ROE) track record: 3 Years ROE 35.5%", "Debtor days have improved from 131 to 102 days."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.